Page last updated: 2024-11-05

wb 4101 and Diabetes Mellitus, Type 2

wb 4101 has been researched along with Diabetes Mellitus, Type 2 in 1 studies

N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Artasensi, A1
Angeli, A1
Lammi, C1
Bollati, C1
Gervasoni, S1
Baron, G1
Matucci, R1
Supuran, CT1
Vistoli, G1
Fumagalli, L1

Other Studies

1 other study available for wb 4101 and Diabetes Mellitus, Type 2

ArticleYear
Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101.
    Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20

    Topics: Adrenergic Agents; Caco-2 Cells; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diabetes Mellit

2022